JNJ 26854165
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | JNJ-26854165 is one of p53-activating agents and synergizes with AraC or doxorubicin to induce p53-mediated apoptosis and may provide a novel therapeutic approach for the treatment of acute leukemias. |
---|
Catalog Num | A10491 |
---|---|
Formula | C21H20N4 |
Molecular Weight | 328.4 |
CAS Number | 881202-45-5 |
SMILES | C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4 |
Synonyms | JNJ26854165 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 56 mg/mL (170.51 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (6.08 mM) | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 30.45 mL | 152.25 mL | 304.51 mL |
0.5 mM | 6.09 mL | 30.45 mL | 60.9 mL |
1 mM | 3.05 mL | 15.23 mL | 30.45 mL |
5 mM | 0.61 mL | 3.05 mL | 6.09 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2